The California Senate passed a bill that would allow pharmacies to sell patient information to third-party marketers, including drug companies. It was sent to the California Assembly for consideration.
The bill would allow a pharmacy to send mail to a patient without the patient’s authorization on condition that the letter pertain only to the prescribed course of medical treatment; not mention any other pharmaceutical products; be copied to the FDA’s Division of Drug Marketing, Advertising and Communications; and include disclosures about whether the pharmacy receives direct or indirect remuneration for making the written communication, among other conditions. The patient must receive an opportunity to opt out of the mailings.
[…]
The bill, California S.B. 1096, can be viewed at info.sen.ca.gov/pub/07-08/bill/sen/sb_1051-1100/sb_1096_bill_20080523_amended_sen_v96.pdf
Source – FDA News